NO20013832L - Piperidin- og piperazinderivater som hemmere ved Abeta-fibril- dannelsen - Google Patents

Piperidin- og piperazinderivater som hemmere ved Abeta-fibril- dannelsen

Info

Publication number
NO20013832L
NO20013832L NO20013832A NO20013832A NO20013832L NO 20013832 L NO20013832 L NO 20013832L NO 20013832 A NO20013832 A NO 20013832A NO 20013832 A NO20013832 A NO 20013832A NO 20013832 L NO20013832 L NO 20013832L
Authority
NO
Norway
Prior art keywords
piperidine
inhibitors
piperazine derivatives
fibril formation
abeta
Prior art date
Application number
NO20013832A
Other languages
English (en)
Other versions
NO20013832D0 (no
Inventor
Rainer Martin Lueoend
Markus Baenziger
Peter Frey
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20013832D0 publication Critical patent/NO20013832D0/no
Publication of NO20013832L publication Critical patent/NO20013832L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/08—Aza-anthracenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/08—Diarylmethoxy radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Piperidin- og piperazinderivater som hemmere ved Abeta-fibril-dannelsen En forbindelse med formel (I) der X er (II) eller (III) der R' er en gruppe (a) R er en gruppe (e) eller (f) (a) (e) der n er O til 3. Spesielt hemmer midlene ifølge oppfinnelsen dannelsen av p-amyloid (AP) peptid til neurotoksiske fibriler, som derved virker hindrende eller modererende på akkumuleringen av amyloidproteinavsetninger i hjernen.
NO20013832A 1999-02-10 2001-08-06 Piperidin- og piperazinderivater som hemmere ved Abeta-fibril- dannelsen NO20013832L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9902938.1A GB9902938D0 (en) 1999-02-10 1999-02-10 Organic compounds
PCT/EP2000/001000 WO2000047571A1 (en) 1999-02-10 2000-02-08 Piperidine and piperazine derivatives as inhibitors of the abeta fibril formation

Publications (2)

Publication Number Publication Date
NO20013832D0 NO20013832D0 (no) 2001-08-06
NO20013832L true NO20013832L (no) 2001-09-27

Family

ID=10847440

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013832A NO20013832L (no) 1999-02-10 2001-08-06 Piperidin- og piperazinderivater som hemmere ved Abeta-fibril- dannelsen

Country Status (20)

Country Link
US (1) US20020002170A1 (no)
EP (1) EP1150971A1 (no)
JP (1) JP2002536441A (no)
KR (1) KR20010102006A (no)
CN (1) CN1337960A (no)
AR (1) AR022542A1 (no)
AU (1) AU2803200A (no)
BR (1) BR0008068A (no)
CA (1) CA2362389A1 (no)
CO (1) CO5140091A1 (no)
CZ (1) CZ20012868A3 (no)
GB (1) GB9902938D0 (no)
HU (1) HUP0200133A3 (no)
ID (1) ID29283A (no)
IL (1) IL143779A0 (no)
NO (1) NO20013832L (no)
PE (1) PE20001460A1 (no)
SK (1) SK11372001A3 (no)
TR (1) TR200101924T2 (no)
WO (1) WO2000047571A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7053127B1 (en) * 2002-09-16 2006-05-30 Nalco Company Quaternized amido cyclic amine surfactant
CN1764458A (zh) * 2003-03-26 2006-04-26 麦克公司 作为黑皮质素－4受体激动剂的双环哌啶衍生物
RU2336270C2 (ru) * 2003-06-30 2008-10-20 Дайити Фармасьютикал Ко., Лтд. Гетероциклические метилсульфоновые производные
CN106866657A (zh) * 2017-04-25 2017-06-20 成都倍特药业有限公司 一种麦角新碱的制备方法
CR20200225A (es) 2017-11-24 2020-07-25 H Lundbeck As Nuevos fármacos de catecolamina para uso en el tratamiento de la enfermedad de parkinson
US11104697B2 (en) 2019-05-20 2021-08-31 H. Lundbeck A/S Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1- propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11130775B2 (en) 2019-05-20 2021-09-28 H. Lundbeck A/S Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11111263B2 (en) 2019-05-20 2021-09-07 H. Lundbeck A/S Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
US11168056B2 (en) 2019-05-20 2021-11-09 H. Lundbeck A/S Process for the manufacturing of (6aR,10aR)-7-propyl-6,6a,7,8,9,10,10a,11-octahydro-[1,3]dioxolo[4′,5′:5,6]benzo[1,2-G]quinoline and (4aR,10aR)-1-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[G]quinoline-6,7-diol
JP7562562B2 (ja) 2019-05-21 2024-10-07 ハー・ルンドベック・アクチエゼルスカベット パーキンソン病の治療に使用するための新規なカテコールアミンプロドラッグ
EP3972600B1 (en) 2019-05-21 2026-02-18 H. Lundbeck A/S Catecholamine carbamate prodrugs for use in the treatment of parkinson s disease
JP7641234B2 (ja) 2019-05-21 2025-03-06 ハー・ルンドベック・アクチエゼルスカベット パーキンソン病の治療に使用するための新規なカテコールアミンプロドラッグ
EP3972971A1 (en) 2019-05-21 2022-03-30 H. Lundbeck A/S New catecholamine prodrugs for use in the treatment of parkinson's diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW357143B (en) * 1995-07-07 1999-05-01 Novartis Ag Benzo[g]quinoline derivatives
US6060483A (en) * 1996-06-27 2000-05-09 Pharmacia & Upjohn S.P.A. Antineurodegenerative ergoline derivatives
GB9701628D0 (en) * 1997-01-27 1997-03-19 Pharmacia & Upjohn Spa Imino-aza-anthracyclinone derivatives

Also Published As

Publication number Publication date
US20020002170A1 (en) 2002-01-03
ID29283A (id) 2001-08-16
HUP0200133A3 (en) 2003-01-28
TR200101924T2 (tr) 2002-01-21
CN1337960A (zh) 2002-02-27
NO20013832D0 (no) 2001-08-06
CZ20012868A3 (cs) 2001-10-17
GB9902938D0 (en) 1999-03-31
AR022542A1 (es) 2002-09-04
HUP0200133A2 (en) 2002-06-29
IL143779A0 (en) 2002-04-21
JP2002536441A (ja) 2002-10-29
WO2000047571A1 (en) 2000-08-17
KR20010102006A (ko) 2001-11-15
BR0008068A (pt) 2001-11-13
CO5140091A1 (es) 2002-03-22
PE20001460A1 (es) 2001-01-03
SK11372001A3 (sk) 2001-12-03
EP1150971A1 (en) 2001-11-07
AU2803200A (en) 2000-08-29
CA2362389A1 (en) 2000-08-17

Similar Documents

Publication Publication Date Title
DE69839305D1 (de) Aminderivate, ihre herstellung und verwendung als inhibitoren der produktion von amyloid-beta
NO960393L (no) Heterosykliske fenylforbindelser som COX-2-inhibitorer
ATE199552T1 (de) Substituierte benzolaktamverbindungen als substanz-p-antagonisten
NO20032801L (no) Tiazolderivater for behandling av PPAR-relaterte forstyrrelser
EA200101133A1 (ru) Способ ингибирования агрегации амилоидных белков и визуализации амилоидных отложений с использованием производных изоиндолина
DE69732571D1 (de) Beta-sulfonyl-hydroxamsäuren als matrix-metalloproteinaseinhibitoren
NO20012984L (no) Succinoylamino benzodiazepiner som inhibitorer av AB proteinproduksjon
ATE272398T1 (de) Verwendung von ep4 rezeptorliganden zur behandlung von neuropathischen schmerz
NO986055D0 (no) Nye heterocykliske forbindelser, deres fremstilling, farmas÷ytiske preparat
DE60031577D1 (de) Hemmer der zelladhäsion
EA200100972A1 (ru) Новые соединения и композиции как ингибиторы протеаз
ATE236632T1 (de) Inhibitoren der protein-isoprenyl-transferase
ES2184960T3 (es) Nuevas pirimidin-4-onas-(5,6)-heteroaril condensadas 2,3 disustituidas.
ATE154937T1 (de) Steroide zur behandlung von prostatisch- hypertrophe, ihre herstellung und verwendung
EA200400699A1 (ru) 3,4-дизамещенные, 3,5-дизамещенные и 3,4,5-замещенные пиперидины и пиперазины
NO983992L (no) Serinprotease inhibitorer
NO20005261L (no) Nye heterocyklisk substituerte amider med cystein-protease- inhiberende virkning
PE20011085A1 (es) Compuestos isoxazolquinolin o imidazolquinolin como inhibidores de la proteina resistente a multifarmacos
ID24846A (id) Turunan-turunan bifenilamidina
TR200101924T2 (tr) Abeta fibril oluşumunun inhibitörleri olarak, piperidi ve piperazin türevleri
UA66756C2 (uk) Сполуки піперазину та піперидину, спосіб одержання сполук та спосіб лікування розладів центральної нервової системи
DE69431359T2 (de) Prolyl-endopeptidaseinhibitoren
DK1077218T3 (da) Peptidomimetiske forbindelser omfattende RGD-sekvenser, som er nyttige som integrininhibitorer
TR200103551T2 (tr) Amiloid protein birikimini önleme ve amiloid tortularını görüntüleme metodu
DE60113407D1 (de) Verfahren zur hemmung von amyloidprotein aggregation und zur diagnostischen nachweis von amyloidablagerung unter verwendung von aminoindanderivaten

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application